• Beta-2 Microglobulin, Spinal Fluid
  • Tapentadol, Urine
  • Influenza Virus Type A, B and Respiratory Syncytial Virus (RSV), PCR
  • BCR-ABL Translocation by RT-PCR, Quantitative, Blood
  • Benign neoplasm, ovary
  • HIV Co-Receptor Tropism (Trofile) Assay
  • Blastomyces Antigen, Quantitative, Serum
  • Biopsy, Endomyocardial
  • Malignant neoplasm, ovary
  • Cytochrome P450 21A2 (CYP21A2) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
Medical Test

Interpretation
Access to UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue is restricted.